Drugs@FDA document
BESREMI Medication Guide · BLA 761166 SUPPL-13
Drugs@FDA document · PHARMAESSENTIA CORP · Sep 1, 2026
Key facts
| Drug name | BESREMI |
|---|---|
| Document type | Medication Guide |
| Application | BLA761166 |
| Submission | SUPPL-13 |
| Company | PHARMAESSENTIA CORP |
| Document date | Sep 1, 2026 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-New Indication Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: